Publicacións nas que colabora con Adrián Sousa Dominguez (24)

2024

  1. A comprehensive, predictive mortality score for patients with bloodstream infections (PROBAC): a prospective, multicentre cohort study

    Journal of Antimicrobial Chemotherapy, Vol. 79, Núm. 8, pp. 1794-1800

  2. Mortality impact of further delays in active targeted antibiotic therapy in bacteraemic patients that did not receive initial active empiric treatment: Results from the prospective, multicentre cohort PROBAC

    International Journal of Infectious Diseases, Vol. 145

2023

  1. A Confounder in the Study of a Patient With Infective Endocarditis

    JACC: Case Reports, Vol. 28

  2. Carbapenem alternatives for treatment of bloodstream infections due to AmpC producing enterobacterales

    Annals of Clinical Microbiology and Antimicrobials, Vol. 22, Núm. 1

  3. Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial

    Nature Medicine, Vol. 29, Núm. 10, pp. 2518-2525

  4. Impact of Methylprednisolone Pulse on the Mortality of Patients With Acute Respiratory Distress Syndrome Secondary to COVID-19

    Infectious Diseases in Clinical Practice, Vol. 31, Núm. 6

  5. Mycotic Aortic Aneurysm after Intravesical Bacillus Calmette-Guérin Instillation for Bladder Carcinoma

    Infectious Diseases in Clinical Practice

2022

  1. Gastrointestinal colonization by OXA-48-producing Enterobacterales: risk factors for persistent carriage

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 41, Núm. 12, pp. 1399-1405

  2. Oral sequential therapy in the treatment of post-surgical epidural abscess and subdural empyema

    Infection, Vol. 50, Núm. 5, pp. 1385-1389

  3. Successful ceftazidime–avibactam therapy in a patient with multidrug-resistant Pseudomonas aeruginosa infective endocarditis

    Infection

2021

  1. Clinical characteristics, aetiology and mortality/recurrence risk factors of acute cholangitis in patients with and without biliary stent

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 9, pp. 445-450

  2. Impact of the COVID-19 pandemic on the diagnosis, management and prognosis of infective endocarditis

    Clinical Microbiology and Infection

  3. Mortality-related factors in patients with OXA-48 carbapenemase-producing Klebsiella pneumoniae bacteremia

    Medicine, Vol. 100, Núm. 14, pp. e24880

  4. The benefits and safety of oral sequential antibiotic therapy in non-complicated and complicated Staphylococcus aureus bacteremia

    International Journal of Infectious Diseases, Vol. 102, pp. 554-560

  5. Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)

    Clinical Microbiology and Infection, Vol. 27, Núm. 2, pp. 244-252

2019

  1. Moving beyond unsolicited consultation: Additional impact of a structured intervention on mortality in Staphylococcus aureus bacteraemia

    Journal of Antimicrobial Chemotherapy, Vol. 74, Núm. 4, pp. 1101-1107

  2. Short- versus long-course therapy in gram-negative bacilli bloodstream infections

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 38, Núm. 5, pp. 851-857

  3. Validation of a clinical decision tree to predict if a patient has a bacteraemia due to a β-lactamase producing organism

    Infectious Diseases, Vol. 51, Núm. 1, pp. 32-37

2018

  1. Clinical and microbiological characteristics of unusual manifestations of invasive pneumococcal disease

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 36, Núm. 5, pp. 284-289

  2. Effectiveness of ceftazidime/avibactam as salvage therapy for treatment of infections due to OXA-48 carbapenemase-producing Enterobacteriaceae

    Journal of Antimicrobial Chemotherapy, Vol. 73, Núm. 11, pp. 3170-3175